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(57) ABSTRACT 
The present invention provides a device for detecting the 
presence of an analyte, wherein said analyte is a microor- 
ganism marker gas. The device comprises a sample chamber 
having a fluid inlet port for the influx of the microorganism 
marker gas; a fluid concentrator in flow communication with 
the sample chamber, wherein the fluid concentrator has an 
absorbent material capable of absorbing the microorganism 
marker gas and thereafter releasing a concentrated microor- 
ganism marker gas; and an array of sensors in fluid com- 
munication with the concentrated microorganism marker 
gas. The sensor array detects and identifies the marker gas 
upon its release from fluid concentrate. 
33 Claims, 8 Drawing Sheets 
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However, one obvious drawback is that the Halimeter 
cannot distinguish between volatile sulfur compounds. 
Similarly, other volatile substances can interfere with the 
readings of the VSC. 
A second device for the detection of breath and odors 
associated therewith is based on zinc-oxide thin film semi- 
conductor technology and has recently been developed for 
measuring VSC (see, Shimura M et. al., J. Periodontol. 
67:396-402 (1994)). New Cosmos Electric Co. (Osaka, 
i o  Japan) manufactures this device. This device, however, is 
limited because it is susceptible to interference from organic 
vapors unrelated to oral malodor (see, Yaegaki K, In 
Rosenberg, “Bad Breath: Research Perspectives,” Proceed- 
ings of the First International Workshop on Oral Malodor, 
is Ramot Publishing, Tel Aviv University pp. 41-54 (1993)) 
87-108 (1995)). 
Another analysis for breath detection is a test based on the 
enzyme substrate benzoyl-DL-arginine-naphthylamine 
(BANA) (see, Loesche et  al., J .  Clin. Microbiol. 
20 28:1551-1559 (1991); and Loesche etaL J. Periodontol., 
61:189-196 (1991)). This test is marketed under the brand 
name Peroscan and is available from Oral-B Laboratories 
(Redwood City, Calif.). Scrapings from the tongue, saliva, or 
plaque samples are deposited directly on a reagent card. 
25 Following substrate addition, a blue spot develops if anaer- 
obes are present. Studies have shown that BANAresults are 
not highly correlated with VSC measurements and that the 
test is often detecting other analytes (see, Kozlovsky et al., 
J. Dent. Res., 73:1036-1042 (1994)). 
It has been estimated that at least 50% of the population 
suffers from chronic oral malodor (see, Bosy, J. Can. Dent. 
Assoc. 63:196-201 (1997)). A significant fraction of the 
population is worried about bad breath, even though there is 
usually no underlying disease (see, Iwakura et cl., J. Dent. 
35 Res. 7:1568-1574 1 (1994)). Food, of course, is another 
cause of oral malodors. However, there are many people 
who have an unwarranted phobia of bad breath. The size of 
the market for breath fresheners, chewing gums, and mouth 
rinses is an indicator of this propensity. 
In addition to mammalian breath measurements, respira- 
tory devices for anesthetic and respiratory gas mixtures must 
be monitored at very low concentrations of analytes. Medi- 
cal devices mix the anesthetic with breathing gas prior to 
delivery to the patient. In an anesthetic device, it is impera- 
45 tive that the concentration of the anesthetic, gas flow and 
amounts of the mixture and starting gases be known with 
certainty. In most instances, the anesthetic amounts are at 
very low concentration levels. 
One approach to increase sensitivity to certain analytes is 
SO to use selective filters or membranes. For instance, U.S. Pat. 
No. 5,841,021, which issued to De Castro et al., discloses an 
electrochemical gas sensor that has a catalytically active 
sensor electrode, a reference electrode and a permselective 
filter or membrane layer. The filter is made of a material that 
ss provides for molecular specificity of certain gases, such as 
carbon monoxide. The membrane allows the sensors to be 
selective to the chemical analyte of interest. The filter only 
allows the analytes of interest to contact the sensor. By 
removing interfering substances through filtration, the sen- 
60 sor becomes more selective and thus sensitive to the analyte 
of interest. 
In addition, U.S. Pat. No. 5,057,436, which issued to Ball, 
discloses a method and apparatus for detection of toxic 
gases, such as ammonia, using a metal oxide semiconductor 
65 and an electrochemical sensor. Disposed between the two 
sensors is an absorber having an absorbent that reacts with 
ammonia. 
s 
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TRACE LEVEL DETECTION OF ANALYTES 
USING ARTIFICIAL OLFACTOMETRY 
CROSS-REFERENCES TO RELATED 
APPLICATIONS 
This application claims priority to U.S. Provisional appli- 
cations Ser. No. 601090,012, filed Jun. 19,1998, and 601091, 
179, filed Jun. 30, 1998, the disclosures of which are 
incorporated herein by reference in their entirety. 
STATEMENT AS TO RIGHTS TO INVENTIONS 
MADE UNDER FEDERALLY SPONSORED 
RESEARCH AND DEVELOPMENT 
The research carried out in the subject application was 
sponsored, in part, by grants from: ARO (DAAG-55-97-1- 
0187); DARPA (DAAK60-97-K-9503); and NASA (49- 
244-30002-0-8280), and is subject to the provisions of 
Public Law 96-517 (35 U.S.C. 5 202). The government may 
have certain rights in any patents issuing on this application. 
BACKGROUND OF THE INVENTION 
An artificial olfactory system is a device that is capable of 
detecting a wide variety of analytes in fluids such as vapors, 
gases and liquids. The device comprises an array of sensors 
that in the presence of an analyte produces a response. The 
device produces a unique signature output for a particular 
analyte. Using pattern recognition algorithms, the output 
signature, such as an electrical response, can be correlated 
and compared to a particular analyte or mixture of sub- 
stances that are known. By comparing the unknown signa- 
ture with the stored or known signatures, the analyte can be 
detected, identified and quantified. 
There are many instances where it is desirable to measure 
trace amounts of analytes. However, in certain instances, the 
analytes are found at levels that are too low to register a 
robust signal by direct exposure to currently available sen- 
sors. In headspace analysis of applications in agricultural, 
wine, tobacco, perfume, plastics, and the food industries, the 
detection and classification of trace levels of gases are 
present in the sub part per million (ppm) range, making 
detection difficult. Moreover, in residue analysis of pesti- 
cides on crops, the trace levels of certain herbicides must 
meet federal guidelines. For certain crops, these residues are 
present on the crops in the part per billion levels (ppb). 
Another potential application wherein the detection of 
trace levels of analytes is important is the diagnosis of 
patients’ conditions from an analysis of their breath. Marker 
gases such as hydrogen sulfide and methyl mercaptan, which 
are important in diagnosing the presence of oral or lung 
conditions from the breath of human patients, often exist in 
concentrations of 0.01-1 parts per million (or lower). 
However, the threshold detection levels of currently known 
sensors are in the range of 1-100 parts per million. 
Currently, the most widely used device for detecting oral 
malodors is the Halimeter, which is commercially available 
from Interscan Corp. (Chatsworth, Calif.). Using an elec- 
trochemical cell that is sensitive to volatile sulfur com- 
pounds (VSC), the device can oxidize the VSC at the anode 
according to the following reactions: 
H2S-S+2H’+2e 
2 C H 3 S H - C H 3 S S 4 H 3 + S + 2 H f + 2 e  
CH3S4H3+2H20-2CH30H+S+2H++2e 
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In view of the foregoing, what is needed in the art is a 
vapor concentrator for an array of sensors, especially for an 
electronic nose sensor array. In addition, methods are needed 
to detect odors and diagnose medical conditions. The present 
invention fulfills these and other needs. 
SUMMARY OF THE INVENTION 
In certain instances, it is desirable to measure trace 
amounts of analytes using sensor array technology. The 
present invention increases the sensitivity to such analytes 
by a large factor, and thus allows for the use of existing 
sensor systems for applications where an increase in sensi- 
tivity renders them more effective. As such, in certain 
aspects, the present invention provides a device for detecting 
the presence of an analyte, the device comprising: a sample 
chamber having a fluid inlet port for the influx of the analyte; 
a fluid concentrator in flow communication with the sample 
chamber, wherein the fluid concentrator has an absorbent 
material capable of absorbing the analyte and capable of 
desorbing a concentrated analyte; and an array of sensors in 
fluid communication with the concentrated analyte. In cer- 
tain preferred embodiments, the device further includes a 
detector operatively associated with each sensor that pro- 
vides a response in the presence of the analyte. 
The absorbent material of the fluid concentrator can be, 
but is not limited to, a nanoporous material, a microporous 
material, a chemically reactive material, a nonporous mate- 
rial and combinations thereof. In certain instances, the 
absorbent material can concentrate the analyte by a factor 
that exceeds a factor of about lo5, and more preferably by 
a factor of about 10’ to about lo4. Using the device of the 
present invention, the analyte can be concentrated from an 
initial sample volume of about 10 liters and then desorbed 
into a concentrated volume of about 10 milliliters or less, 
before being presented to the sensor array. 
In another embodiment, removal of background water 
vapor is conducted in conjunction, such as concomitantly, 
with the concentration of the analyte. Once the analyte is 
concentrated, it can be desorbed using a variety of 
techniques, such as heating, purging, stripping, pressuring or 
a combination thereof. 
In yet another aspect, the present invention provides 
methods for detecting or diagnosing, for example, 
infections, lung cancer, oral infections and halitosis using a 
breath sample of a mammal. Preferably, the mammal is a 
human being. In other embodiments, the present invention 
provides methods for other medical applications, such as 
those involving the detection of marker gas(es) in mamma- 
lian breath as well as odors from potentially infected areas 
of the skin. 
In still yet another aspect, the present invention provides 
methods and devices for the process control of anesthetic 
gases of clinical interest. Using the apparatus of the present 
invention, monitoring and quantitating anesthetics is readily 
accomplished. 
These and other embodiments and advantages will be 
readily apparent when read with the accompany drawings 
and the detailed description of the invention which follows. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a cross-sectional view of a breath collector and 
FIG. 2 is a cross-sectional view of a breath collector and 
FIG. 3 is a head space analyzer of the present invention. 
concentrator of the present invention. 
concentrator of the present invention. 
4 
FIG. 4 is a block diagram of a vaporizing system of the 
present invention. 
FIG. 5 illustrates various response patterns obtained using 
the devices of the present invention. Panel A illustrates the 
5 responses of 32 sensors to anerobius (Bacl), gingivalis 
(Bac2) and a control; Panel B illustrates responses of 32 
sensors to anerobius (Bacl), gingivalis (Bac2) and a control 
(Expanded y-axis). 
FIG. 6 illustrates the results of principle component 
lo analysis on a data set of Ps anerobius (Bacl) and P gingivalis 
bacteria (Bac2) plus the control (the medium in which the 
bacteria were grown). 
FIG. 7 illustrates the response of sensors in the presence 
FIG. 8 illustrates the results of the response of sensor 
15 of 3 percent halothane. 
array in the presence of halothane. 
DETAILED DESCRIPTION OF THE 
INVENTION AND PREFERRED 
EMBODIMENTS 
I. The Device 
20 
In one aspect, the present invention allows existing sensor 
25 systems to be more effective and efficient by providing 
enhancements in the detection sensitivity to trace analytes. 
As such, in one embodiment, the present invention provides 
a device for detecting the presence of an analyte in a fluid, 
comprising: 
a) a sample chamber having a fluid inlet port for the influx 
of the analyte; 
b) a fluid concentrator in flow communication with the 
sample chamber, the fluid concentrator having an 
absorbent material capable of absorbing the analyte and 
capable of desorbing a concentrated analyte; and 
c) an array of sensors in fluid communication with the 
concentrated analyte. 
In preferred embodiments, the device further comprising 
a detector operatively associated with each sensor that 
40 provides a response in the presence of an analyte. In certain 
embodiments, the sample chamber is designed for the col- 
lection of mammalian breath. Under certain conditions, 
mammalian breath contains marker gases indicative of cer- 
tain infections, disorders and medical conditions and the 
45 devices of the present invention can be used to detect such 
marker gases. In certain aspects, the sample chamber is a 
breath collector and concentrator (BCC) and is fabricated to 
collect the breath of a mammal. Preferably, the mammal is 
a human being, although the BCC can be fabricated to 
SO collect the breath of other mammals such as cows, sheep, 
horses, dogs, cats, hogs, etc. The BCC is convenient to use 
and in certain instances is a portable handheld device with 
a suitable handle portion for convenient use. 
With reference to FIG. 1, in certain embodiments, the 
ss sample chamber is a cylindrical reservoir having an inlet 
port (10) for the influx of gas, such as breath, and an outlet 
port (19) for the exhaust of breath. The BCC has a first end 
and a second end. The cylindrical container (12) extends 
between the first end and the second end, and the cylindrical 
The first end of the body is open for access to the interior 
chamber and functions as a breath inlet port and is vented by 
a breath exhaust. The breath inlet port optionally contains a 
disposable adapter for multiple use. A concentrator portal 
65 (14) opens into the interior chamber and is in flow commu- 
nication with the fluid concentrator. The fluid concentrator 
(15) comprises an absorbent material capable of absorbing 
3o 
35 
60 container has an open interior chamber (13). 
US 6,244,096 B3 
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the analyte and capable of desorbing a concentrated analyte. 
In certain embodiments, valves control the breath flow so the 
sample of breath within the chamber can be directed to the 
fluid Concentrator. The fluid concentrator optionally contains 
a second exhaust or exit port. 
(16) is mounted anterior to the Outlet Port with 
suficient force to maintain the vent closed except when the 
Optionally, the HSA contains appropriate connections for 
high throughput screening (HTS). High throughput screen- 
ing includes a robotic armature system. In general, these 
systems include automated workstations like the automated 
s apparatus developed by Takeda Chemical Industries, LTD. 
(Osaka, Japan) and many robotic systems utilizing robotic 
(Zymate 11, zymark corporation, ~ ~ ~ k i ~ ~ ~ ~ ,  M ~ ~ ~ , ;  
A 
is into the chamber. Optionally, the fluid 
concentrator is jacketed (17) with a heater for the PUTose Of 
Orca, Hewlett-packard, Palo Alto, Calif,), which mimic the 
manual operations performed by a technician, The nature desorbing a concentrated analyte. As illustrated in FIG. 1, 
the BCC has a sensor array portal (18) that opens into the 
desorbed concentrated analyte and the sensor array (11). In 
and implementation of modifications to these devices (if 
interior chamber and is in fluid communication with the any) so that they can 'perate be apparent to persons in the art. 
certain embodiments, the Sensor array is disposed down- 
stream of the inlet port and the concentrator portal. In other 
In Operation, a Of the gas to be such as 
chamber where it human breath, is introduced into a 
embodiments, the array is disposed between the inlet IS is transported by means of convention into the vicinity of the 
port and the concentrator portal (not shown), certain sorbent material. Suitable transporting means include, but 
embodiments, the BCC has an adapter to provide breath are not limited to, a fan, an air Pump, Or it can be means for 
from the nostril(s) to avoid cross-contamination from the heating the cylindrical container (12) to create a convective 
mouth. air flow between the inlet and the outlet. The sorbent 
In certain aspects, the BCC can be a desktop model. As 20 material is chosen from known materials designed for the 
illustrated in FIG. 2, the first end (24) of the BCC (20) is purpose of sorbing gases, vapors, and the like. In certain 
open for access to the interior chamber (22) and functions as embodiments, the sorbent material includes, but is not 
a breath inlet port and is vented by a breath exhaust (25). A limited to, a nanoporous material, a microporous material, a 
fluid concentrator (23) opens into the interior chamber (27) chemically reactive material, a nonporous material and 
and is in flow communication (28) with the breath exhaust zs combinations thereof Such absorbents include, for example, 
(25). In this embodiment, the breath is circulated through the activated carbon, silica gel, activated alumina, molecular 
chamber using a fan (21). The sensor array (26) is in flow sieve carbon, molecular sieve zeolites, silicalite, AIPO,, a 
communication with the desorbed analyte. polymer, a co-polymer, alumina and mixtures thereof In 
In various embodiments, the fluid concentrator can be certain embodiments, the absorbent has a pore size from 
disposed within the sample chamber or outside the sample 30 about 1 nm to about 100 nm and, preferably, from about 1 
chamber. In addition, the sensor array can be disposed nm to about 50 nm. 
within the sample chamber or outside the sample chamber. Suitable commercially available adsorbent materials are 
Moreover, the sensor array can be configured to be external disclosed in U.S. patent application Ser. No. 091271873, 
from the BCC and to extend into the mouth or nasal cavity. filed Mar. 18, 1999, and include, but are not limited to, 
The present invention embodies all such variations. 3s Tenax TA, Tenax GR, Carbotrap, Carbopack B and C, 
Although the device of FIG. 1 is shown as a handheld Carbotrap C, Carboxen, Carbosieve SIII, Porapak, 
breath collector and concentrator, those of skill in the art will Spherocarb, and combinations thereof Preferred adsorbent 
appreciate that in certain other embodiments, the device and combinations include, but are not limited to, Tenax GR and 
methods of the present invention can be adapted and con- Carbopack B; Carbopack B and Carbosieve SIII; and Car- 
figured to detect within or around various other areas of 40 bopack C and Carbopack B and Carbosieve SI11 or Car- 
interest including, but not limited to, mucous membranes, boxen 1000. Those skilled in the art will know of other 
nose, nasal passages, eye, skin, ear, inner ear, mouth, tongue, suitable absorbent materials. 
throat, colon, duodenum, body cavities, stomach, vagina and After sometime period that is chosen to be adequate for 
penis. Moreover, the device and methods of the present sorbing the desired analytes from the vapor phase onto the 
invention can be confinured to detect all bodv fluids 4s material. the circulation is stoaaed and then the material is v 
including, but not limited to, urine, perspiration, tears, 
blood, mucus, pus, salvia, feces, menstruation fluid, sperm, 
eggs, spinal fluid and mammary gland discharge. 
In another embodiment, the sample chamber is a head 
space analyzer (HSA) and can be fabricated from an inert 
material, such as a molded fiberglass, or in certain embodi- 
ments can be fabricated from plastic and can be configured 
like a box. As illustrated in FIG. 3, the sample chamber (32) 
optionally has a glass-viewing window and the box can 
contain pressure and temperature gauges (37) to allow 
pressure and temperature monitoring. Moreover, the sample 
I I  
desorbed from the sorbent phase and released into the sensor 
chamber. The desorbing of the concentrated analyte for the 
sorbent can be by accomplished by thermal means, mechani- 
cal means or a combination thereof Desorption methods 
SO include, but are not limited to, heating, purging, stripping, 
pressuring or a combination thereof. 
In certain embodiments, the sample concentrator is 
wrapped with a wire through which current can be applied 
to heat and thus, desorb the concentrated analyte. The 
ss analyte is thereafter transferred to the sensor array. 
The process of sorbing the material onto the sorbent phase 
chamber optionally contains valves for gas input and not only can be used to concentrate the material, but also can 
exhaust of the box. Optionally, the sample chamber com- be advantageously used to remove water vapor. The water 
prises a heater and a pressure control means for an internally vapor is preferably removed prior to concentrating the 
controlled atmosphere. 60 analyte; however, in various embodiments, the vapor can be 
Similar to the BCC, the HSA has a first end (34) that is removed concomitantly or after the analyte is concentrated. 
open for access to the interior chamber (32) and functions as In a preferred embodiment, the water vapor is removed prior 
an inlet port (30) and is vented by an exhaust (35). A fluid to presenting the desired analyte gas mixture to the sensor 
concentrator (33) is disposed outside the sample chamber array. Thus, in certain embodiments, the fluid concentrator 
and is in flow communication (36) with the exhaust (35). 65 contains additional absorbent material to not only concen- 
The sensor array (39) is in flow communication with the trate the analyte, but to remove unwanted materials such gas 
desorbed analyte. contaminates and moisture. 
US 6,244,096 B3 
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In certain instances and depending on the absorbent used, 
the concentration factor can exceed a factor of lo5, and more 
preferably by a factor of about 10’ to about lo4. Thus, the 
analyte gases can be concentrated from an initial sample 
volume of about 10 liters and then desorbed into a volume 
of about 10 milliliters or less when they are presented to the 
sensor array. 
The array of sensors is present in fluid communication 
with the concentrated analyte. Various sensors suitable for 
detection of analytes include, but are not limited to: surface 
acoustic wave (SAW) sensors; quartz crystal microbalance 
sensors; conductive composites; chemiresitors; metal oxide 
gas sensors, such as tin oxide gas sensors; organic gas 
sensors; metal oxide field effect transistor (MOSFET); 
piezoelectric devices; infrared sensors; temperature sensors, 
humidity sensors, sintered metal oxide sensors; Pd-gate 
MOSFET; metal FET structures; metal oxide sensors, such 
as a Tuguchi gas sensors; phthalocyanine sensors; electro- 
chemical cells; conducting polymer sensors; catalytic gas 
sensors; organic semiconducting gas sensors; solid electro- 
lyte gas sensors; piezoelectric quartz crystal sensors; dye- 
impregnated polymer films on fiber optic detectors; 
polymer-coated micromirrors; electrochemical gas detec- 
tors; chemically sensitive field-effect transistors; carbon 
black-polymer composite chemiresistors; micro-electro- 
mechanical system devices; and micro-opto-electro- 
mechanical system devices and Langmuir-Blodgett film 
sensors. 
In a preferred embodiment, the sensors used in the present 
invention are disclosed in U.S. Pat. No. 5,571,401, which is 
incorporated herein by reference. Briefly, the sensors 
described therein are conducting materials and nonconduct- 
ing materials arranged in a matrix of conducting and non- 
conducting regions. The nonconductive material can be a 
nonconducting polymer such as polystyrene. The conductive 
material can be a conducting polymer, carbon black, an 
inorganic conductor and the like. The sensor arrays comprise 
at least two sensors, typically about 32 sensors, and in 
certain instances 1000 or more sensors up to about lo6 
sensors. In a preferred embodiment, at least two sensors are 
compositionally different. The array of sensors can be 
formed on an integrated circuit using semiconductor tech- 
nology methods, an example of which is disclosed in PCT 
Patent Publication No. WO99108105, entitled “Techniques 
and Systems for Analyte Detection,” published Feb. 19, 
1999, and incorporate herein by reference. Another preferred 
sensor system is disclosed in PCT Patent Publication No. 
WO99127357, published Jun. 6, 1999. 
In certain embodiments, the temporal response of each 
sensor (response as a function of time) is recorded and can 
be displayed. Various responses include, but are not limited 
to, resistance, impedance, capacitance, inductance, 
magnetic, optical, etc. The temporal response of each sensor 
can be normalized to a maximum percent increase and 
percent decrease that produces a response pattern associated 
with the exposure of the analyte. By iterative profiling of 
known analytes, a structure-function database correlating 
analytes and response profiles is generated. Unknown ana- 
lytes can then be characterized or identified using response 
pattern comparison and recognition algorithms. 
Accordingly, analyte detection systems comprising sensor 
arrays, a measuring device for detecting responses across 
each sensor, a computer, a display, a data structure of sensor 
array response profiles, and a comparison algorithm(s) or 
comparison tables are provided. In another embodiment, the 
electrical measuring device or detector is an integrated 
circuit comprising neural network-based hardware and a 
8 
digital-analog converter (DAC) multiplexed to each sensor, 
or a plurality of DACs, each connected to different sensor(s). 
In certain embodiments, a method for using the sensors 
for detecting the presence of an analyte in a fluid involves 
s sensing the presence of an analyte in a fluid with a chemical 
sensor comprising first and second conductive leads electri- 
cally coupled to and separated by a chemically sensitive 
sensor as described above by measuring a first response 
between the conductive leads when the sensor is contacted 
i o  with a first fluid comprising an analyte at a first concentra- 
tion and a second different response when the sensor is 
contacted with a second fluid comprising the analyte at a 
second different concentration. As discussed above, suitable 
responses include, but are not limited to, resistance, 
is impedance, capacitance, inductance, magnetic, optical, etc. 
11. Medical Applications 
The methods and apparatus of the present invention are 
extremely useful and can be advantageously used for the 
2o detection, identification, and classification of trace gas 
components, and are extremely useful in a variety of 
applications, including medical applications. In certain 
aspects, the methods and devices of the present invention are 
useful and very effective for the detection and diagnosis of 
25 diseases. In general, certain volatile marker gas(es) charac- 
terizes the detection or diagnosis of a disease state or 
medical condition. The methods and apparatus of the present 
invention can advantageously by used to detect volatile 
marker gases and compounds indicative of medical 
30 conditions, disease processes, infections, illness and well- 
being. Using these marker gases and compounds, clinicians 
can use the diagnostic instruments and methods of the 
present invention to make diagnoses and formulate appro- 
priate treatments. The methods as described can optionally 
35 be performed using a fluid concentrator as described herein. 
A. Oral infections 
In certain aspects, the present invention is extremely 
useful for the detection of infections, such as oral infections 
4o and dental cares. For example, bacteria cause two wide- 
spread dental problems -halitosis and periodontal disease- 
and, as disclosed herein, the methods and apparatus of the 
present invention can detect the off-gases produced by such 
bacteria. 
45 1. Halitosis 
Halitosis is caused by the breakdown of proteins by 
microbes on the back of the tongue. The tongue coating is 
comprised of epithelial cells from the oral mucosa, leuko- 
cytes from periodontal pockets, and microorganisms. While 
50 the mouth is resident to over 300 bacterial species (see, 
Loesche et al., In Rosenberg M., Editor, “Bad Breath: 
Research Perspectives,” Proceedings of the First Interna- 
tional Workshop on Oral Malodor, Ramot Publishing, Tel 
Aviv University pp. 41-54 (1993)), the relative size of each 
55 population is a function of many factors. Bad breath has 
been associated with the expansion of anaerobic species 
(see, Loesche et al, In Rosenberg Ed., “Bad Breath: 
Research Perspectives,” Proceedings of the First Interna- 
tional Workshop on Oral Malodor, Ramot Publishing, Tel 
60 Aviv University pp. 41-54 (1993); de Boveri HE et al., J. 
Am. Dent. Assoc., 126:1384-1393 (1995)). The underlying 
cause of the increase in anaerobes can be poor oral hygiene, 
aging, deep crevices in the tongue, post-nasal drip, or 
numerous other conditions. 
The chemical markers of bad breath have been identified 
and include, but are not limited to, volatile sulfur com- 
pounds (VSC) (see, Richter et al., Arch. Oral Biol., 9:47-53. 
65 
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(1964); Tonzetich, Arch. Oral Biol., 16:587-597 (1971); 
Tonzetich, J. Periodontol. 48:13-20 (1977); Tonztich J, J. 
Int. Dent. J. 28:309-319 (1978); and Tonzetich, Arch. Oral 
Biol., 16:587-597 (1971)). 
As such, the present invention provides a method for the 
detection of halitosis, the method comprising: contacting an 
array of sensors with mammalian breath suspected of con- 
taining a marker gas indicative of halitosis; and detecting the 
marker gas to determine the presence of halitosis. In pre- 
ferred embodiments, the marker gases being detected by the 
sensors are volatile sulfur compounds. 
2. Periodontal Disease 
A far more serious consequence of oral infections is 
periodontal disease. Gingivitis is the inflammation of the 
gums and periodontitis is when the gum infection damages 
the bone and supporting tissues. These conditions are the 
result of the expansion of certain species of bacteria. If a 
piece of food is trapped between the teeth, the bacterial types 
that can utilize the various nutrients present will multiply. In 
addition, some of their metabolic products can give rise to 
a second array of organisms. And finally, if the population 
explosion of bacteria is sufficient to elicit an inflammatory 
response, a third wave of bacteria can arise that prefers the 
gingival crevicular fluid (see, Loesche WJ et al., In 
Rosenberg, Bad Breath Research Perspectives, Ramot 
Publishing, Tel Aviv, pp. 41-54 (1993)). 
VSC are also an indicator of periodontal disease (see, 
Loesche et al., In Rosenberg, Bad Breath: Research 
Perspectives,Ramat Publishing, Tel Aviv, (1995); Yaegaki et 
al., J. Periodontia. Res. 27:233-238 (1992); Tonzetich et al., 
J. Dent. Res 58:175 (1979); Frostell et aL, Dent. J. 
20:436-450 (1970); Sat0 et al., Bull. Tokyo Dent. Coll., 
21:171-178 (1980); Kostelcetal., J .  Periodontal Res. 
15:185-192 (1980)). In addition, a number of other com- 
pounds can be indicative of various bacterial populations 
(see, Bosy et al., J. Periodontal. 65:3746 (1994); McCulloch 
et al., In Rosenberg, Bad Breath Research Perspectives, 
Ramat Publishing, Tel Aviv, pp. 109-117 (1995)). 
Asignificant development in recent years has been the use 
of anti-microbials to treat periodontitis instead of surgery. It 
has been shown that 80% of patients scheduled for surgery 
or extractions could be successfully treated with a course of 
metronidazole, doxycycline, or chlorhecidine. Overall, only 
about 10% of the teeth required the conventional surgery or 
extraction. Surprisingly, by using the apparatus of 
However, these methods suffer from lack of specificity. 
While the absence of odor is indicative of a clean wound, the 
presence of odor does not necessarily signal an infection. 
The switch in recent years to moisture-retaining “wet dress- 
ings” has further complicated the problem of wound assess- 
ment. Most dressings have strong odors, but often times the 
odor is due entirely to the materials in the dressings. 
While there is a quantitative culture methodology that can 
be employed to eliminate human errors, it is very expensive 
and time consumingh such, it is only used routinely in burn 
centers where patients are in much more serious conditions. 
Advantageously, the present invention provides a method 
for diagnosing wound healing comprising: contacting the 
vapors associated with the wound with an array of sensors, 
thereby assessing the wound healing process. 
D. Vaginitis 
The vaginal discharge of women with bacterial vaginitis 
often has a prominent fishy odor. The presence of 
methylamine, isobutylamine, putrescine, cadaverine, 
histamine, tyramine, and phenethylamine are marker gases 
of vaginitis (see, Brand et al., Obstetrics and Gynecology, 
10 
68,682-685 (1985)). Thus, the present invention provides a 
method for the detection of vaginitis, the method compris- 
ing: contacting an array of sensors with vaginal vapors or 
discharge suspected of containing a marker gas indicative of 
s vaginitis; and detecting the marker gas to determine the 
presence of vaginitis. 
E. Fertility 
In yet another aspect, the present invention provides 
methods and apparatus for the detection of ovulation. The 
lo fertile period of a female mammal, such as a human being, 
can be detected by measuring axillary secretions. The mark- 
ers are androstenol and/or dehydroepiandrosterone sulfate. 
Thus, the present invention provides a method for detecting 
ovulation, the method comprising: contacting an array of 
sensors with vaginal vapor for the presence of a marker gas 
indicative of ovulation; and detecting the marker gas to 
determine ovulation. the present invention, it is possible to 
make a quick diagnosis, thereby alleviating unnecessary 
surgery. 
As such, the methods and apparatus of the present inven- 
tion can be used for the detection of periodontal disease. 
Thus, the present invention provides a method for the 
detection of periodontal disease, the method comprising: 
25 contacting an array of sensors with mammalian breath 
suspected of containing a marker gas indicative of periodon- 
tal disease; and detecting the marker gas to determine the 
presence of periodontal disease. As explained above, and 
detailed hereinbelow, numerous marker gases can be used to 
20 
3o detect and evaluate the severity of periodontal disease. 
B. Pneumonia Detection 
In certain instances, it currently takes two to three days to 
culture the bacteria and determine whether the species that 
cause pneumonia are present. Often, rather than waiting for 
35 this determination, medical personnel prescribe broad- 
spectrum antibiotics. Unfortunately, this prophylactic pro- 
cedure can promote the emergence of antibiotic-resistant 
strains. 
The methods and devices of the present invention can 
40 alleviate the unnecessary prescribing of antibiotic(s) by 
providing rapid accurate detection and diagnosis of bacteria 
attributable to pneumonia. Thus, the present invention pro- 
vides a method for the detection of pneumonia, the method 
comprising: contacting an array of sensors with mammalian 
45 breath suspected of containing a marker gases indicative of 
pneumonia; and detecting the marker gas to determine the 
presence of pneumonia. 
C. Wound healing 
One of the major reasons for slow healing wounds can be 
a high level of bacteria. Frequently, wound healing is largely 
undetected due to lack of tests for detecting microorganisms. 
Slow wound healing is a problem that effects more than a 
million people each year and costs billions of dollars to treat. 
55 Unfortunately, one of the standard techniques of wound 
assessment is to smell the exudate on the dressing. Nurses 
are advised to be aware of a “repulsive” odor that may be 
associated with necrotic tissue and “acrid or putrid” smells 
that are associated with anaerobic bacteria. 
60 F. OTHER APPLICATIONS 
In addition to the foregoing applications, other applica- 
tions for the methods and devices of the present invention 
include, but are not limited to, environmental toxicology, 
remediation, biomedicine, material quality control, food 
65 monitoring, agricultural monitoring, heavy industrial 
manufacturing, ambient air monitoring, worker protection, 
emissions control, product quality testing, oiligas petro- 
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chemical applications, combustible gas detection, H,S 
monitoring, hazardous leak detection, emergency response 
and law enforcement applications, explosives detection, 
utility and power applications, foodlbeverageiagriculture 
applications, freshness detection, fruit ripening control, fer- 
mentation process monitoring and control, flavor composi- 
tion and identification, product quality and identification, 
refrigerant and fumigant detection, cosmeticiperfume 
applications, fragrance formulation, chemicaliplasticsi 
pharmaceut icals  appl icat ions,  fugi t ive emission 
identification, solvent recovery effectiveness, hospital/ 
medical applications, anesthesia and sterilization gas 
detection, infectious disease detection, breath analysis and 
body fluids analysis. 
Various other medical conditions and associated patho- 
gens are set forth in Table 1 
TABLE 1 
Infection 
INFECTIONS AND PATHOGENS 
Pathogen 
Area of 
Interest 
Acute sinusitis 
Pharyngitis 
Pneumonia 
Bronchitis 
American Thoracic 
Society (ATS) Class 111 
CAP 
Severe CAP 
ATS Class IV-ICU 
Cystitis in females; 
Pyelonephritis; Prostatitis 
or Epididymoorchitis 
Acute Meningitis 
Meningitis(post surgical); 
Brain abscess 
Biliary tract; Peritonitis 
or Diverticular abscess 
Cellulitis; Lymphangitis 
Cat bite, Dog bite, 
Decubitus ulcers,(uncom- 
plicated) or Diabetic foot 
ulcer (uncomplicated); 
Toxic Shock 
EndometritisIEndomyo- 
metritis Pelvic Inflam- 
matory Disease; Septic 
Thrombophlebitis (post- 
partum) 
Endocarditis (IE) 
Prosthetic valve 
Septic arthritis, Prosthetic 
joint, Osteomyelitis 
Strep. pneumoniae, H flu, 
Moraxella catarrhalis, Group 
A strep., G(+) anaerobes; 
Staph. aurew 
Group A,C,G strep. 
Strep. pneumoniae, 
Mycoplasma, Chlamydia 
pneumoniae, H flu 
Strep. pneumoniae, H Flu, 
Moraxella 
Strep. pneumoniae, H 
influenzae, Klebsiella, Staph. 
aurew, Legionella Sp., 
Pseudomonas aerug., 
other gram-negative bacteria; 
Strep. pneumoniae, Staph. 
aurew, Legionella Sp., 
Pseudomonas aerug., other 
gram negative bacteria 
Enterobacteriaceae; 
Enterobacteriaceae & 
Enterococcus sp. 
Hemophilus influenzae, 
Pneumococci, N meningitidis 
Staphylococcus sp., gram- 
negative bacteria; 
Streptococcus sp., anaerobes, 
Staph. sp. 
Enterobacteriaceae, 
Enterococcus sp., anaerobes 
Streptococcus sp., 
Staphylococcus sp.; Pastur- 
ella multicida, Staph & Strep., 
anaerobes; Gram negative 
bacteria; Gram-positive 
bacteria; Anaerobes 
Enterobacteriaceae, 
Chlamydia sp., Streptococcus 
sp. (group B Streptococcus), 
Neiserria gonorrhoeae 
Streptococci sp. 
Staphylococcus sp. 
Staphylococcus epi. 
Staphylococcus sp. & Strep. 
sp., Neisseria gonorrhoeae, 
Staphylococcus sp., 
Staphylococcus sp., Staph & 
Strep. sp., Entero- 
bacteriaceae, anaerobes 
Sinus 
Pharynx 
Lungs 
Lungs 
Lung 
Urinary 
Tract 
CNS 
Abdomen 
Skin 
Pelvis 
Heart 
Bone & Joint 
G. Markers 
As explained above, volatile sulfur compounds (e.g., H,S, 
C H , S H ,  CH,S-CH,) are the marker gases implicated 
S 
10 
1s 
20 
2s 
30 
3s 
40 
4s 
so 
5s 
60 
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in halitosis and periodontal diseases (see, Tonzetich, 
Arch.Ora1 Biol., 16:587-597 (1971); Rizzo, Periodontics, 
5:233-236 (1967)). Other analytes that have been shown to 
correlate with such clinical findings include, but are not 
limited to, volatile organic acids (VOA), indoleiskatole 
(indole), and diamines (see, Goldberg et al, J. Dent. Res., 
73:1168-1172 (1994); Goldberg et al., In Rosesberg M Bad 
Breath Research Perspectives, Ramat Publishing, Tel Aviv, 
pp. 71-85 (1995)). 
In addition, several other analytes have been reported to 
be associated with oral infections including pyridines/ 
picolines (see, Kostelc et al., J Periodont. Res., 15:185-192 
(1981); Kostelc et al., Clin. Chem., 27342-845 (1981)). 
Overall, more than 80 volatile compounds have been shown 
to be associated with saliva or tongue scrapings (see, Claus 
et al., J High ResoL Chromatogr., 20:94-98 (1997)) and the 
methods and apparatus of the present invention can be used 
to advantageously detect such marker compounds and gases. 
Using the methods and apparatus of the present invention 
it is also possible to detect the off-gasses associated with 
bacteria associated with oral maladies including, but not 
limited to, Pvevotella intevmedia; Fusobacterium nuclea- 
tum; Povphyvomonas gingivalis; Povphyvomonas endodon- 
talis; Pvevotella loescheii; Hemophilus pavainfuenzae; Sto- 
matococcus muci; Treponema denticola; Veillonella 
species; Peptostveptococcus anaevobius; Micros pvevotii; 
Eubacterium limosum; Centipeda peviodontii; Selemonad 
avemidis; Eubacterium species; Bacteviodes species; Fuso- 
bacterium periodonticum; Pvevotella melaninogenica; 
Klebsiella pneumoniae; Entevobactev cloacae; Citvobactev 
species and Stomatococcus mucilaginus. 
Moreover, a wide variety of analytes and fluids can be 
detected and analyzed using the disclosed sensors arrays and 
electronic noses so long as the subject analyte(s) and fluids 
are capable of generating a differential response across a 
plurality of sensors of the array. Analyte applications include 
broad ranges of chemical classes including, but not limited 
to, organics such as alkanes, alkenes, alkynes, dienes, ali- 
cyclic hydrocarbons, arenes, alcohols, ethers, ketones, 
aldehydes, carbonyls, carbanions, polynuclear aromatics 
and derivatives of such organics, e.g., halide derivatives, 
etc.; biomolecules such as sugars, isoprenes and isoprenoids; 
VOC; VOA; indoles; skatoles; diamines; pyridines; 
picolines; fatty acids; and derivatives of the forgoing, etc. 
In addition to breath, the sensor arrays of the present 
invention can be used to identify various analytes in other 
biological fluids. These fluids include, but are not limited to, 
urine, perspiration, tears, blood, mucus, pus, salvia, feces, 
menstruation fluid, sperm, eggs, spinal fluid and mammary 
gland discharge. 
In general, most conditions and diseases listed herein 
have microorganisms associated with them. The presence of 
marker gases and compounds associated with the microor- 
ganism is in turn, indicative of the presence of the disease or 
condition. In a preferred embodiment, the off-gas of the 
microorganism is the marker that is detected by methods and 
devices of the present invention. 
111. ANESTHETICS 
In certain anesthetic vaporizers, a carrier gas, such as air, 
oxygen or nitrous oxide, is divided between a first stream 
directed to a chamber, wherein an anesthetic liquid is 
resident and a second stream or bypass stream. The first and 
second streams are recombined before delivery to the 
patient. Another version of an anesthetic vaporizer is 
embodied in a device wherein the anesthetic agent is 
injected directly into the carrier gas stream. 
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In either instance, it is imperative that the concentration of posed of mixtures of polymers and carbon black for metabo- 
volatile anesthetic liquid be known. The present invention lites produced by a variety of bacteria. Fourteen fresh 
provides methods and an apparatus for the process control of cultures were tested for the 20 most commonly suspected 
anesthetic gases. Using the methods and apparatus of the ndodor  Producing, oral and Pharyngeal anaerobic and fat- 
present invention, a fluid concentrator is opt iona~~y used s ultative bacteria including a fungus using a 32-sensor array. 
when monitoring and quantitating anesthetic concentration. The was done in two Phases. The first Phase 
consisted of testing two very distinct bacteria, peptostveplo- 
possible to detect and quantitate the concentration of volatile control (the media in which the bacteria were independently 
By the apparatus and described herein, it is coccus anevobius and povphyvomonas gingivalis, plus a 
anesthetics but not limited to, grown), Four sample tubes of each bacterium and the control 
isoflurane, servoflurane, desflurane and enflurane. As such, lo were tested to investigate reproducibility, The results from 
the Present invention Provides an anesthetic vaporizing the first test indicated that gingivalis and anerobius could be 
system for quantitating the concentration of the anesthetic, discriminated from each other and the control using a 
comprising: a carrier gas source for delivering a carrier gas array discussed herein, 
stream to a bypass valve, wherein the bypass valve splits the Ten samples of eleven bacteria, a fungus and ten controls 
carrier gas stream into a first carrier gas stream for delivery were tested with the Same Sensor array used described 
to an inlet port and a second carrier gas stream for delivery above. Table 3 lists the bacteria plus the main metabolite 
to a joining valve; known to be produced by these bacteria. Various statistical 
a vaporizing chamber for an anesthetic agent, comprising and mathematical techniques were used to analyze the data 
the inlet port, an outlet port, a vaporizing means and a obtained with chemiresistors on these microorganisms. One 
conduit for delivery of vaporized anesthetic from the outlet 2o of the methods used to classify the metabolites produced 
port to the joining valve; and from the various bacteria was principal component analysis, 
in flow commun~cat~on with the an unsupervised pattern recognition technique. PCA trans- 
joining valve to quantitate the anesthetic, preferred forms multidimensional data sets into a lower dimensional 
embodiments, the system further comprising a detector graphical representation, which describes a majority of the 
operatively associated with each that provides a 2s variation in a data set. PCAdefines a new set of axes to plot 
response in the presence of an anesthetic vapor. the samples, they are constructed so that a maximum amount 
of variation is described with a minimum number of axes, With reference to FIG. 4, the carrier gas source (41) and the data is hence readily visualized in this transformed delivers the carrier gas to a bypass valve (44), wherein the data space (see, K. R. Beebe, R. J. Pell, M. B. Seasholtz, carrier gas is split between a first carrier gas stream for 30 Chemometrics: A Practical Guide, Wiley, N.Y., 1998.) delivery to the inlet port (45) of the anesthetic vaporizer (40) 
and a second carrier gas stream which connects to a joining to the data set was Fisher 
valve (46), The anesthetic vaporizer contains a vaporizing Linear Discrimination (FLD). FLD seeks a linear combina- 
means, such as a heater, pressure or aspirator (48), tion of the variables, which maximizes the ratio of its 
an array of 
&lother 
The vaporizer includes an outlet port (42) for delivery of the 3s between-group variance to its within-group variance (see, B. 
vaporized anesthetic through a conduit (43) to the joining 
valve, The Sensor array (49) is in flow communication with 
D. Ripley, Pattern Recognition and 
versity Press, 
Networks, 
1996, Chapter 3, P 93.). 
the joining valve. 
The present invention also provides a method of quanti- 
tating an anesthetic vapor, comprising: containing the anes- 40 
thetic vapor with a sensor array to produce a response; 
detecting the response with a detector, thereby quantitating 
the anesthetic vapor. 
The following examples are meant to illustrate and not 
limit the present invention. 
Other algorithms used to analyze the data were K-nearest 
neighbor (KNN) and statistical isolinear multicategory 
analysis, SIMCA. Both of these algorithms are supervised 
pattern recognition methods used for predicting the class of 
unknown samples given a training set of samples with 
known class membership. With KNN, a classification is 
always made, whether or not the unknown is a member of 
the class in the training set, KNN is a much simpler 
algorithm than SIMCA because unlike SIMCA it makes no 
assumptions about the size or shape of the class. SIMCAcan 
detect if an unknown sample is not a member of any class 
in the training set. SIMCAuses the shape and position of the 
object formed by the samples in a class for class definition 
(see, K. R. Beebe, R. J. Pell, M. B. Seasholtz, Chemomet- 
rics: APractical Guide, Wiley, New York, 1998). The results 
obtained using all the described algorithms are set forth 
below. 
4s 
IV. EXAMPLES 
Example 1 
In this Example, the detection and identification of bac- 
teria was conducted by measuring the metabolic products 
produced from plate bacteria cultures carried out using an 
electronic nose (a 32-sensor array) and a Fisher Linear 
A. EXPERIMENTAL Discrimination (FLD) algorithm. 
As shown herein, the data was also examined using 1. Testing Protocol 
principal component analysis (PCA) and statistical isolinear Thirty polymers were chosen based both on structural 
multicategory analysis (SIMCA). The results carried out on differences and on solubility to generate a thirty two sensor 
two very distinct bacteria, i.e., peptoseptococcus anevobius array. The testing protocol used for all the bacteria was the 
and povphyvomonas gingivalis, show that the two bacteria 60 same and is described below. Anerobius and gingivalis were 
were clearly discriminated by the sensors as shown by PCA. tested in one day, whereas the rest of the bacteria were tested 
The metabolites of additional an 11 bacteria and one fungus over several days. 
plus controls were tested and the data was examined using Testing instrument: A Keithley electrometer and scanner 
PCA, SIMCA and FLD and discrimination among the bac- were used to scan the resistances of 32 sensors during the 
teria was demonstrated. 65 experiment. 
The objective of these experiments was to evaluate the Sampling: the headspace above the bacteria was sampled 
discriminating capability of a thirty-two sensor array com- using nitrogen gas as the carrier. The flow rate used was 100 
so 
5s 
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mL/minute. No dilution with air was done. The flow rate of 
the background air used to purge the sensors was 10 
L/minute. No preconcentration was preformed. 
Temperature: The temperature of the substrates was not 
controlled and the measurements were done at room tem- 
perature for the first phase study. The temperature of the 
substrates was maintained at 28"+0.1" C. for the second 
phase study. 
Purge and Exposure times: For each sample test, there 
were 60 seconds of background recording (purged with air), 
120 seconds of exposure time, 120 seconds of recovery time 
(purged with air with RH level of about 3%), 180 seconds of 
recovery without recording the data (purged with air), and 
30 seconds of final recording time (purged with air). 
B. RESULTS AND DISCUSSION 
1. Sensor Array Response 
The response pattern of the 32-sensor array described 
above to anerobius, gingivalis, and the control is shown in 
FIG. 5 .  Note that the reproducibility of the sensor array was 
very good. The response (the normalized resistance change, 
(Rmm-R,)/RO), where R,, and R, are the maximum and 
base (initial) resistance, respectively) of the sensor array to 
each sample tested is employed to form a covariance matrix, 
which is used to do principal component analysis. PCA of 
the two bacteria plus control (data not shown) were clearly 
discriminated by the sensor array. SIMCA was also used to 
evaluate the data. The model was built with all the data as 
the training set and the data from the first test was used as 
the unknown. A classification rate of 100 % was obtained 
using the SIMCA algorithm. KNN was also used to examine 
the data set. A model was built using the data from three 
sample tubes of each bacteria plus the control. One of the 
samples was used as the unknown. Using 3 or 5 nearest 
neighbors in the KNN algorithm gave a classification rate of 
66%. The FLD algorithm was not used on this data set. 
In the second phase study, ten samples of 11 bacteria and 
one fungus were tested. The temperature of the substrates 
was controlled at 28+0.1" C. for all tests. The sample tubes 
were not temperatures controlled. As described in the experi- 
mental section, each bacterium was tested 19 times among 
9 test tubes. Thirty-two sensors responded to 11 bacteria and 
one fungus, 19 times for each. A covariance matrix that 
contained 32 columns (one column for each sensor 
response) and 12x19 rows (bacteria tested at different times) 
was formed. This matrix was used to do principal compo- 
nent analysis. 
A different algorithm, Fisher Linear Discrimination, was 
introduced to process the data set. To construct a model 
using the FLD method, it is required that the data take the 
form of a square matrix. The columns and rows in the matrix 
correspond to the number of sensors and the number of test 
samples, respectively. Hence, to use FLD, the number of 
sensors needs to be equal to the number of sample tests. 
Each of the 11 bacteria and one fungus were tested 19 times 
thus, only 19 sensors could be used to construct the FLD 
model. Hence, a square matrix was formed using each of the 
bacteria tested 19 times and choosing 19 sensors out of the 
32. The very first test (tube 1) and the last test (tube 5) of 
each bacterium were used as unknowns. The first 19 sensors 
out of the 32-sensor array were found to give the highest 
prediction rate out of other sensor combinations. Twenty- 
four unknowns were predicted from the FLD model. The 
results provided a classification rate of 91.7% (see, Gibson, 
T. D., Prosser, O., Hulbert, J. N., Marshall, R. W., Corcoran, 
P., Lowery, P., Ruck-Keene, E. A,, Heron, S., Sensors and 
Actuators (B) 44, 413422,  1997). 
16 
As a comparison, a SIMCAmodel was built with the same 
training set used for the FLD analysis. The same 24 
unknowns was used for SIMCA prediction. The results 
provided a classification rate of 75%. The KKN algorithm 
was also used and the classification rate was 66%. 
TABLE 2 
SENSOR COMPOSITION AND DEPOSITION CONDlTIONS 
P'er Sensor Dilution 
# Polymer # Solvent Ratio 
10 
15 
20 
25 
30 
35 
40 
45 
so 
19 
22 
34 
35 
36 
55 
73 
74 
3 
10 
12 
39 
42 
41 
48 
so 
54 
59 
63 
68 
80 
87 
95 
79 
63 
79 
86 
82 
90 
104 
105 
102 
CHIP EM-1-070798 
Hycroxypropyl cellulose 
Methyl vinyl ether-co-maleic acid, 
50/50 
Polyacrylamide 
Polyacrylamide, carboxyl modified 
(LC) 
Polyacrylamide, carboxyl modified 
(HC) 
Poly(ethy1ene oxide) 
Poly(viny1 alcohol), 100% 
hydrolyzed 
Poly(viny1 alcohol), 98% 
hydrolyzed 
CHIP EM-2-070798 
Alginic acid, sodium salt 
Ethylene-co-ethyl acrylate, 82/18 
Ethylene-co-vinyl acetate, 86/14 
1,2-Polybutadiene 
Polycaprolactone 
Poly(n-butyl methacrylate) 
Poly(n-ethyl methacrylate) 
Polyethylene, chlorinated (42& Cl) 
CHIP EM-3-070798 
Polyethylene, chlorosulfonated 
Poly(isobuty1 methacrylate) 
Poly(a-methyl styrene) 
Polystyrene 
Poly(viny1 stearate) 
Styrenelethylenebutylene, ABA 
block 
Vinyl chloridelvinyl acetate/ 
hydroxypropyl 
Poly(viny1 pyrrolidone) 
CHIP EM-4-070798 
Poly(a-methyl styrene) 
Poly(viny1 pyrrolidone) 
Styrene-co-butyl methacrylate 
Styrene-co-acrylonitryle, 75/25 
Vinyl alcohol-co-vinyl butyral; 20180 
Poly (4-methoxy styrene) 
Poly methyl hydrosiloxane 
Poly diphenoxyphosphazene 
Sr 1 water 150 to 1 
Sr 2 water 151 to 1 
Sr 3 water 150 to 1 
Sr 4 water 150 to 1 
Sr 5 water 150 to 1 
Sr 6 water 150 to 1 
Sr 7 water 150 to 1 
Sr 8 water 150 to 1 
Sr 9 toluene 25 to 1 
SrlO toluene 25 to 1 
Srll toluene 25 to 1 
Sr12 toluene 25 to 1 
Sr13 toluene 25 to 1 
Sr14 toluene 25 to 1 
Sr15 toluene 25 to 1 
Sr16 toluene 25 to 1 
Sr17 toluene 25 to 1 
Sr18 toluene 25 to 1 
Sr19 toluene 25 to 1 
Sr20 toluene 25 to 1 
Sr21 toluene 25 to 1 
Sr22 toluene 25 to 1 
Sr23 toluene 25 to 1 
Sr24 water 150 to 1 
Sr25 toluene 25 to 1 
Sr26 water 150 to 1 
Sr27 toluene 25 to 1 
Sr28 THF 100 to 1 
Sr29 THF 100 to 1 
Sr30 THF 100 to 1 
Sr31 THF 100 to 1 
Sr32 THF 100 to 1 
carbon black was used in each sensor at a concentration between 20-25 
wt % 
55 TABLE 3 
LIST OF BACTERIA AND THEIR METABOLIC PRODUCTS 
NOMEN- METABOLIC PRODUCTS 
BACTERIA NOMENCLHURE OR OFF-GASES 
6o Enterobacter Bac 1 Isobutyric and isovaleric acid 
cloacae 
Cit. Koseri Bac 2 NIA 
Psuedomonas Bac 3 NIA 
Aeruginosa 
Veilonella species Bac 4 Acetic and propionic acid and 
Prevotella Bac 5 Isovaleric acid 
65 isoamyl alcohol 
US 6,244,096 B3 
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TABLE 3-continued 
18 
TABLE 4-continued 
LIST OF BACTERIA AND THEIR METABOLIC PRODUCTS 18 SENSOR ARRAYS 
NOMEN- METABOLIC PRODUCTS Sensor Polymer and carbon black Carbon black 
BACTERIA NOMENCLATURE OR OFF-GASES 
0.156 g in 20 ml THF 
3. Poly (a-methylstyrene) [25014-31-71 41 mg carbon black melaninogenica 
Escherichia coli 
Klebseilla 
Pneumoniae 
Streptococcus 
mutans 
Tandiaa 
albicam 
Prevotella 
intermedia 
Fusobacterium 
nucleatum 
Staph. aureus 
Peptostrepto- 
coccus anerobius 
Porphyromonas 
gingivalis 
Bac 6 
Bac 7 
Acetic and propionic acid 
Methyl ethyl ketone, methyl- 
butanal, 2-butanol, pentanone, 
dimethyl sulfide, isobutanol, 
isopentylacetate, 2-heptanone 
isopentanol, 2-nonanone, 
2-undecanone 
Acetic acid, propionic acid Bac 8 
Bac 9 NIA 
Bac 10 Isovaleric acid 
Bac 11 Acetic, propionic and 
Bac 12 Acetic, 2-butanone, 2-butanol, 
butyric acid 
pentanone, methyl butanol, 
toluene, 2-heptanone, iso- 
pentanol, 2-nonanone, 2-unde- 
canone, acetone, 2-nondecagon 
Acetic, isobutyric, butyric, 
isovaleric and isocaproic acid 
Isovaleric acid 
*This is a fungus 
30 
Example 2 
This Example illustrates that the apparatus and methods 
comprising the sensor arrays of the present invention are 
suitable for process control of anesthetic gases. As disclosed 3 s  
herein, a method for monitoring anesthetic gases in order to 
establish reliable monitoring of a patient’s condition while 
under anesthetics is possible. Conducting-polymer compos- 
ite sensors change resistance when exposed to an analyte in 
the vapor phase, and the pattern of such resistance changes 40 
across an array allows identification of a concentration of an 
analyte. The pattern height allows identification of the 
concentration of an analyte. The experiments show that 
these arrays are suitable for process control over the con- 
centration of anesthetic gases at levels that are clinically of 4s  
interest. 
Using a 18-sensor array a suitable concentration of hal- 
othane was delivered. The flow rate of the carbon dioxide 
carrier gas was 10 mL/min. The anesthetic gas flow rate was 
0.2 mL/min, thus the ratio of carrier gas flow over the 
summation of the carrier gas flow and the anesthetic gas flow 
was 2%. FIG. 7 illustrates the response of 2% halothane on 
the sensor array. FIG. 8 illustrates the linear response for 
sensor 10 with halothane concentration. 
55 
TABLE 4 
. .  
Aldrich 
0.164 g in 20 ml THF 
[9003-22-91 
10% vinyl acetate 
Polysciences Cat #07058 
0.164 g in 20 ml THF 
10 4. Poly(viny1 chloride - vinylacetate) 39 mg carbon black 
5. Poly(viny1 pyrrolidone) [9003-39-81 41 mg carbon black 
15 Aldrich 
Average Mw 10,000 
(both in TFSH @ 6 mglml) 
0.160 g in 20 ml THF 
Polysciences 
MW: 500,000 
0.163 g in 20 ml 
anhydride) [9011-16-91 
Polysciences Cat #0303 
0.162 g in THF 
6. Poly(viny1 acetate) [9003-20-71 42 mg carbon black 
20 
7. Poly(methy1 vinyl ether - maleic 39 mg carbon black 
8. Poly(bispheno1 A carbonate) 39 mg carbon black 
25 [24936-68-31 
MW 32,000-36,000 
Polysciences Cat #00962 
18 SENSOR ARRAYS 
60 Sensor Polymer and carbon black Carbon black 
1. Poly(4-vinyl phenol) [24979-70-21 40 mg Carbon black 
M W  1500-7000 Polysciences Cat 
#06527 
0.160 g in 20 ml THF 
Polysciences Cat #03773 (soluble in THF) 65 
5.7% hydroxyl, MW 1500 
(soluble in THF) 
2. Poly(Styrene-co-alkyllalcohol) .46 mg carbon black 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
0.169 g in 20 ml THF 
Poly(styrene) [9003-53-61 
MW 125,000-250,000 beads 
Polysciences Cat #00574 
0.160 g in THF 
Poly(styrene - maleic anhydride) 
[9011-13-61 
50% of each Mw 1600 
Polysciences Cat #0316 
0.160 g in 20 ml THF 
Poly(viny1 butyral) [63 148-65-21 
Mw 100,000-150,000 
Polysciences Cat #06100 
0.160 g in 20 ml THF 
Poly(su1fone) [25135-51-31 
0.166 g in 20 ml THF 
Mw 30,000 
Polysciences Cat #07074 
Poly(methy1 methacrylate) [9101-14-71 
Aldrich 
Average Mw -120,000 
Contains 4 . 0 %  toulene 
0.162 g in 20 ml THF 
Poly(viny1idene chloride - acrylonetrile) 40 mg carbon black 
[9010-76-81 
0.161 g in THF 
Polysciences cat. #09747 
Poly(capro1actone) [24980-41-41 
Polysciences cat. #07039 
Biodegradable polymer 
0.159 g in 20 ml benzene 
Poly(ethy1ene - vinyl acetate) 
[24937-78-81 
0.168 g in 20 ml benzene 
82% ethylene 
Polysciences cat. #02309 
Poly(ethy1eneoxide) [25322-68-31 
Aldrich 
Arc Mw 100000 
0.162 g in benzene 
* Sonicated each suspension for 5 min. 
Poly(9-vinyl carbazole) 
Aldrich [25067-59-31 
18,260-5 
Ave. Mw CQ 1,100,000 
0.162 g polymer 
41 mg carbon black 
40 mg carbon black 
41 mg carbon black 
40 mg carbon black 
41 mg carbon black 
(8O:ZO) 
42 mg carbon black 
39 mg carbon black 
42 mg carbon black 
-40 mg carbon black 
US 6,244,096 B1 
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It is understood that the examples and embodiments group consisting of a surface acoustic wave sensor, a quartz 
described herein are for illustrative purposes only and that microbalance sensor; a conductive composite; a chemiresis- 
various modifications or changes in light thereof will be tor; a metal oxide gas sensor and a conducting polymer 
suggested to persons skilled in the art and are to be included sensor, a dye-impregnated polymer film on fiber optic 
within the spirit and purview of this application and scope of 5 detector, a polymer-coated micromirror, an electrochemical 
the appended claims. All publications, patents, and patent gas detector, a chemically sensitive field-effect transistor, a 
applications cited herein are hereby incorporated by refer- carbon black-polymer composite, a micro-electro- 
ence for all purposes in their entirety. mechanical system device and a micro-opto-electro- 
mechanical system device. 
18. A device in accordance with claim 1, wherein said 
analyte is a member selected from the group consisting of 
alkanes, alkenes, alkynes, dienes, alicyclic hydrocarbons, 
arenes, alcohols, ethers, ketones, aldehydes, carbonyls, 
carbanions, polynuclear aromatics, heterocycles, organic 
derivatives, biomolecules, metabolites, sugars, isoprenes 
and isoprenoids, fatty acids and their derivatives. 
19. A device in accordance with claim 1, wherein said 
device is used in an application selected from the group 
consisting of environmental toxicology, remediation, 
biomedicine, material quality control, food monitoring, agri- 
2, A device in accordance with claim 1, further compris- 20 cultural monitoring, heavy industrial manufacturing, ambi- 
product quality testing, oiligas petrochemical applications, 
combustible gas detection, H,S monitoring, hazardous leak 
What is claimed is: 
1. A device for detecting the presence of an analyte, 
wherein said analyte is a microorganism marker gas, said 
device comprising: 
a) a sample chamber having a fluid inlet port for the influx 
of said analyte; 
b) a fluid concentrator in flow communication with said 
sample chamber, said fluid concentrator having an 
absorbent material capable of absorbing said analyte 
and capable of desorbing a concentrated analyte; and 
an array of in fluid communication with said 
concentrated analyte. 
ing a detector operatively associated with each Sensor and ent air monitoring, worker protection, emissions control, 
providing an electrical response in the presence of said 
analyte. 
3. Adevice in accordance with claim 1, wherein said fluid detection, emergency response and law enforcement 
concentrator is disposed within said sample chamber. 25 detection, and power 
4, A device in accordance with claim 1, wherein said applications, foodlbeverageiagriculture applications, fresh- 
ness detection, fruit ripening control, fermentation process 
identification, product quality and identification, refrigerant 
and fumigant detection, cosmeticiperfume applications, fra- 
30 grance formulation, chemicaliplasticsipharmaceuticals 
applications, fugitive emission identification, solvent recov- 
and sterilization gas detection, infectious disease detection, said fluid concentrator and to said sensor array. 
7. A device in accordance with claim 1, wherein said breath analysis and body fluids analysis, 
sample chamber comprises an internally controlled atmo- 35 20, A device in accordance with claim 1, further com- 
sphere. prising robotic armature for high throughput assay screen- 
8. A device in accordance with claim 1, wherein said ing. 
absorbent material is a member selected from the group 21. A device in accordance with claim 1, wherein said 
consisting of a nanoporous material, a microporous material, array of sensors comprise about 10 to about 100 sensors. 
a nonporous material and combinations thereof. 22. A device in accordance with claim 1, wherein said 
9. A device in accordance with claim 8, wherein said array of sensors comprise about 100 to about 1000 sensors. 
absorbent material is a member selected from the group 23. A device in accordance with claim 1, wherein said 
consisting of activated carbon, silica gel, activated alumina, array of sensors comprise about 1000 to about lo6 sensors. 
molecular sieve carbon, molecular sieve zeolites, silicalite, 24. A device in accordance with claim 1, wherein at least 
AlPO,, a polymer, a co-polymer, alumina and mixtures 45 two sensors are compositionally different. 
thereof. 25. A device in accordance with claim 1, further com- 
10. A device in accordance with claim 9, wherein said prising a computer, response profiles and an algorithm. 
absorbent has a pore size from about 1 nm to about 100 nm. 26. A device in accordance with claim 25, wherein said 
11. A device in accordance with claim 10, wherein said algorithm is a pattern recognition algorithm. 
absorbent has a pore size from about 1 nm to about 50 nm. SO 27. A device in accordance with claim 25, further com- 
12. A device in accordance with claim 1, wherein said prising a neural network for software or hardware analysis. 
concentrated analyte is desorbed using a member selected 28. A device in accordance with claim 1, wherein said 
from the group consisting of heating, purging, stripping, device is a handheld device. 
pressuring or a combination thereof. 29. A device in accordance with claim 1, wherein said 
13. A device in accordance with claim 1, further com- ss microorganism marker gas is indicative of a medical 
prising an additional adsorbent to remove unwanted material condition, a disease process, an infection, an illness, or the 
from said analyte fluid. well-being of a mammal. 
14. A device in accordance with claim 13, wherein said 30. A device in accordance with claim 29, wherein said 
unwanted material is a gas contaminate. medical condition is a member selected from the group 
15. A device in accordance with claim 13, wherein said 60 consisting of an ear infection, an oral infection, pneumonia, 
unwanted material is moisture. an infected wound, vaginitis, fertility, acute sinusitis, 
16. A device in accordance with claim 2, wherein said pharyngitis, pneumonia, bronchitis, American Thoracic 
electrical response is a member selected from the group Society Class I11 CAP infection, Severe CAP infection, and 
consisting of electrical resistance, impedance and capaci- Class IV-ICU infection. 
tance. 31. A device in accordance with claim 30, wherein said 
17. A device in accordance with claim 1, wherein said oral infection is a member selected from the group consist- 
array of sensors comprises a member selected from the ing of halitosis and periodontal disease. 
sensor array is disposed within said sample chamber. 
concentrator and said sensor array are disposed within said 
sample chamber. 
6. A device in accordance with claim 5, further compris- 
5,Adevice in accordance with claim 1, wherein said fluid monitoring and f lavor  and 
ing a to flow said analyte fluid from said port to ery effectiveness, hospitalimedical applications, anesthesia 
40 
65 
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32. A device in accordance with claim 1, wherein said selected from the group consisting of Streptococcus 
microorganism marker gas is indicative of a member pneumoniae, Haemophilus influenzae, Movaxella 
selected from the group consisting of bacteria, viruses, and catavvhalis, Mycoplasma pneumoniae, Staphylococcus 
fungi. 
33. A device in accordance with claim 1, wherein said s 
auveus, and Group A streptococcus. 
microorganism marker gas is indicative of a member * * * * *  
